Cargando…
Rituximab: Humoral immune defect and negative seroconversion IgG-spike 1 test: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933194/ http://dx.doi.org/10.1007/s40278-022-11929-3 |
Ejemplares similares
-
IgG-Fc glycosylation before and after rituximab treatment in immune thrombocytopenia
por: Schmidt, David E., et al.
Publicado: (2020) -
Pulmonary IgG4‐related disease with favourable response to rituximab: A case report
por: Muller, Romain, et al.
Publicado: (2022) -
Rituximab-induced IgG hypogammaglobulinemia in children with nephrotic syndrome and normal pre-treatment IgG values
por: Marzuillo, Pierluigi, et al.
Publicado: (2019) -
IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Staines, Henry M., et al.
Publicado: (2021) -
Successful treatment of IgG4‐related hypertrophic pachymeningitis with induction rituximab and dexamethasone followed by maintenance rituximab
por: Seegobin, Karan, et al.
Publicado: (2021)